95.3 / 88.5 FM Grand Rapids and 95.3 FM Muskegon
Play Live Radio
Next Up:
Available On Air Stations

Spectrum Health authorized to administer monoclonal antibodies to non-hospitalized COVID-19 patients

Spectrum Health logo
Spectrum Health

The U.S. Food and Drug Administration is giving Spectrum Health Emergency Use Authorization for two monoclonal antibodies for treating non-hospitalized patients with mild to moderate COVID-19 symptoms.

The two monoclonal antibodies infusion treatments are from pharmaceutical companies Eli Lilly and Regeneron and are being offered at a new infusion clinic at East Grand Rapids' Blodgett Hospital. The intravenous treatment takes one hours. From start to finish, patients will require a three hour stay.

The monoclonal antibodies treatments have shown few side effects and can help to prevent patients from developing severe COVID-19 symptoms.